AMGN (STOCKS)
Amgen Inc
$339.000000
-2.660000 (-0.78%)
Prev close: $341.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert A. Bradway
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $182,129.95M
- Employees
- 28,000
- P/E (TTM)
- 23.76
- P/B (TTM)
- 20.06
- Dividend Yield
- 286.83%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
16
Buy
19
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$5.15 | $4.85 | +0.2978 | +6.14% |
|
Dec 2025 (Q4)
|
$5.29 | $4.83 | +0.4617 | +9.56% |
|
Sep 2025 (Q3)
|
$5.64 | $5.11 | +0.5256 | +10.28% |
|
Jun 2025 (Q2)
|
$6.02 | $5.39 | +0.6276 | +11.64% |
Financial Statements
| Revenues | $37.22B |
| Benefits Costs and Expenses | $28.13B |
| Cost Of Revenue | $11.81B |
| Costs And Expenses | $26.65B |
| Gross Profit | $25.41B |
| Nonoperating Income/Loss | $1.21B |
| Operating Expenses | $14.84B |
| Selling, General, and Administrative Expenses | $6.97B |
| Depreciation and Amortization | $898.00M |
| Other Operating Expenses | $6.98B |
| Operating Income/Loss | $10.57B |
| Income/Loss From Continuing Operations After Tax | $7.80B |
| Income/Loss From Continuing Operations Before Tax | $9.09B |
| Income Tax Expense/Benefit | $1.29B |
| Net Income/Loss | $7.80B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $7.80B |
| Net Income/Loss Available To Common Stockholders, Basic | $7.80B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $14.48 |
| Diluted Earnings Per Share | $14.38 |
| Basic Average Shares | 1,616,000,000 |
| Diluted Average Shares | 1,627,000,000 |
| Assets | $92.50B |
| Current Assets | $31.48B |
| Inventory | $6.19B |
| Other Current Assets | $25.29B |
| Noncurrent Assets | $61.03B |
| Fixed Assets | $8.22B |
| Intangible Assets | $21.38B |
| Other Non-current Assets | $31.43B |
| Liabilities | $83.31B |
| Current Liabilities | $24.96B |
| Accounts Payable | $2.94B |
| Other Current Liabilities | $22.02B |
| Noncurrent Liabilities | $58.36B |
| Long-term Debt | $57.32B |
| Other Non-current Liabilities | $1.04B |
| Equity | $9.19B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.19B |
| Liabilities And Equity | $92.50B |
| Net Cash Flow From Operating Activities | $10.76B |
| Net Cash Flow From Operating Activities, Continuing | $10.76B |
| Net Cash Flow From Investing Activities | -$2.21B |
| Net Cash Flow From Investing Activities, Continuing | -$2.21B |
| Net Cash Flow From Financing Activities | -$5.32B |
| Net Cash Flow From Financing Activities, Continuing | -$5.32B |
| Net Cash Flow | $3.23B |
| Net Cash Flow, Continuing | $3.23B |
| Comprehensive Income/Loss | $7.84B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $7.84B |
| Other Comprehensive Income/Loss | $7.84B |
| Other Comprehensive Income/Loss Attributable To Parent | $41.00M |